LIVESTREAM: http://videoexchange.mayo.edu/webcasts

Behavioral Neurology
Wentao Li, M.D.
“Evaluation of CSF biomarkers of Alzheimer’s disease at Mayo Clinic”

Learning Objectives
Upon conclusion of this activity, participants will be able to:

• Recognize the different AD CSF biomarker scenarios seen in a tertiary neurology practice (and how this may differ from community practice).
• Differentiate biomarker profiles of AD and NPH, discuss the role of the p-Tau/AB42 ratio in the workup for NPH.
• Identify AD CSF biomarker profiles which may be associated with CJD.

The presenter (nor spouse/partner) does not have a relevant financial relationship to disclose.  The presenter does intend to discuss off-label/investigative uses of commercial products/devices: Roche/Elecys – Alzheimer’s Disease CSF Biomarkers

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.